ANTIDEPRESSEUR, NEUROPROTECTEUR, INHIBITEUR DE DEPOT DE BETA-AMYLOIDE ET AGENT ANTI-AGE COMPORTANT UN COMPOSE HETEROCYLIQUE AYANT UNE STRUCTURE SPECIFIQUE
The use of a heterocyclic compound selected from the group consisting of:3,3-dibenzylimidazo[1,2-a]pyridin-2(3H)-one, spiro[imidazo[1,2-a]pyridin-2(3H)-one-3,2'-indan],3,3-dipropylimidazo[1,2-a]pyridin-2(3H)-one,3,3-dibutylimidazo[1,2-a]pyridin-2(3H)-one,5,5-dibenzylimidazo[2,1-b]thiazol-6(5H)-one,3,3-dibenzylimidazo[1,2-a]pyrimidin-2(3H)-one, spiro[imidazo[1,2-a]pyridin-2(3H)-one-3,2'-(4'-fluoroindan)], spiro[imidazo[1,2-a]pyridin-2(3H)-one-3,2'-(4'-cyanoindan)], spiro[imidazo[2,1-a]isoquinolin-2(3H)-one-3,2'-indan], spiro[imidazo[1,2-a]pyridin-2(3H)-one-3,2'-((1,2,5-thiadiazo)[4,5-c]indan)], spiro[imidazo[1,2-a]pyrimidin-2(3H)-one-3,2'-indan],spiro[imidazo[2,1-a]isoquinolin-2(3H)-one-3,4'-(1'-cyclopentene)], 3,3-bis(4-chlorobenzyl)imidazo[1,2-a]pyridin-2(3H)-one, 8-cyclopropylmethyloxy-3,3-diallylimidazo[1,2-a]pyridin-2(3H)-one,spiro[imidazo[1,2-a]pyridin-2(3H)-one-3,2'-(4'-hydroxyindan)], spiro[8-hydroxy-imidazo[1,2-a]pyridin-2(3H)-one-3,2'-indan], spiro[8-methoxyimidazo[1,2-a]pyridin-2(3H)-one-3,4'-(1'-cyclopentene)], and spiro[8-cyclopropylmethyloxyimidazo[1,2-a]pyridin-2(3H)-one-3,4'-(1'-cyclopentene)] asan antidepressant.
